Efficacy of Finasteride for Treating Patients with Androgenetic Alopecia who are Pileous in other Areas: A Pilot Study in Japan

被引:5
|
作者
Inadomi, Toru [1 ]
机构
[1] Ichikawa Rio Dermatol Clin, 3-1-20-1F Ichikawa Minami, Chiba 2720033, Japan
关键词
Androgenetic alopecia; finasteride; pilous;
D O I
10.4103/0019-5154.127677
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Androgenetic alopecia (AGA) involves androgen-dependent hair loss and finasteride is an established treatment for the disease. However, reports of the influence of finasteride on hair growth in other areas of the body are lacking. Aims: To investigate the effects of finasteride on hair, including the head and other areas of the body. Materials and Methods: Based on whether AGA patients felt they were pileous in areas other than the head, they were divided into Group A (pileous) or Group B (not pileous). Finasteride (1 mg/day) was prescribed for both groups for at least 6 months, after which patients were asked to estimate the medicine's effects and any changes of their hair growth. Results and Conclusions: A total of 18 out of 37 patients were placed in Group A and 19 of them were in Group B, suggesting that about half of AGA patients in Japan are pileous in other parts of the body. Oral finasteride was effective (excellent or good) in 22 out of 37 (59.5%) patients overall, in 16 out of 18 (88.9%) patients in Group A, and in 6 out of 19 (31.6%) patients in Group B. None of the patients reported that oral finasteride had any effect on their hair growth other than on their head. Finasteride is more effective for treating AGA patients who are pileous in other areas of the body.
引用
收藏
页码:163 / 165
页数:3
相关论文
共 50 条
  • [21] Efficacy of zoledronate in treating persisting isolated tumor cells in bone marrow in patients with breast cancer - a phase II pilot study
    Rack, B.
    Schindibeck, C.
    Strobl, B.
    Sommer, H.
    Friese, K.
    Janni, W.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2008, 133 (07) : 285 - 289
  • [22] Efficacy and safety of mirabegron, a β3-adrenoceptor agonist, for treating neurogenic bladder in pediatric patients with spina bifida: a retrospective pilot study
    Jee Soo Park
    Yong Seung Lee
    Cho Nyeong Lee
    Sung Hoon Kim
    Sang Woon Kim
    Sang Won Han
    World Journal of Urology, 2019, 37 : 1665 - 1670
  • [23] Efficacy and safety of mirabegron, a β3-adrenoceptor agonist, for treating neurogenic bladder in pediatric patients with spina bifida: a retrospective pilot study
    Park, Jee Soo
    Lee, Yong Seung
    Lee, Cho Nyeong
    Kim, Sung Hoon
    Kim, Sang Woon
    Han, Sang Won
    WORLD JOURNAL OF UROLOGY, 2019, 37 (08) : 1665 - 1670
  • [24] Safety and efficacy of tetrahydrocannibinol (Marinol) in the treatment of agitation in patients with Alzheimer's disease: A pilot study in patients who were refractory to traditional medications
    Shua-Haim, V
    Shua-Haim, J
    Smith, J
    Amin, S
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S85 - S85
  • [25] Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study
    Kawakami, Yoshiiku
    Ochi, Hidenori
    Hayes, Clair Nelson
    Imamura, Michio
    Tsuge, Masataka
    Nakahara, Takashi
    Katamura, Yoshio
    Kohno, Hiroshi
    Kohno, Hirotaka
    Tsuji, Keiji
    Takaki, Shintaro
    Mori, Nami
    Honda, Yohji
    Arataki, Keiko
    Takahashi, Shoichi
    Kira, Shinsuke
    Tamura, Toru
    Masuda, Kazunari
    Nakamura, Toshio
    Kikkawa, Masaya
    Chayama, Kazuaki
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (04) : 548 - 556
  • [26] Efficacy and safety of ledipasvir/sofosbuvir with ribavirin in chronic hepatitis C patients who failed daclatasvir/asunaprevir therapy: pilot study
    Yoshiiku Kawakami
    Hidenori Ochi
    Clair Nelson Hayes
    Michio Imamura
    Masataka Tsuge
    Takashi Nakahara
    Yoshio Katamura
    Hiroshi Kohno
    Hirotaka Kohno
    Keiji Tsuji
    Shintaro Takaki
    Nami Mori
    Yohji Honda
    Keiko Arataki
    Shoichi Takahashi
    Shinsuke Kira
    Toru Tamura
    Kazunari Masuda
    Toshio Nakamura
    Masaya Kikkawa
    Kazuaki Chayama
    Journal of Gastroenterology, 2018, 53 : 548 - 556
  • [27] Evaluation of low-dose tofacitinib combining narrowband UVB therapy for treating vitiligo patients who had failed previous therapy: A pilot study
    Fang, Wei-Cheng
    Chiu, Szu-Hao
    Lin, Sheng-Yiao
    Huang, Shu-Mei
    Lan, Cheng-Che E.
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2021, 37 (04) : 345 - 347
  • [28] The efficacy of robot-assisted training for patients with upper limb amputations who use myoelectric prostheses: a randomized controlled pilot study
    Aydin, Tugba
    Kesiktas, Fatma Nur
    Akbulut, Yusuf Dogan
    corum, Mustafa
    ones, Kadriye
    Kizilkurt, Taha
    Bugdayci, Nazli Derya
    Karacan, Ilhan
    INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH, 2022, 45 (01) : 39 - 46
  • [29] Safety and efficacy of tetrahydrocannibinol (Marinol) in the treatment of agitation in patients with Alzheimer's disease (AD): A pilot study in AD patients who reside in the community, and who were refractory to traditional medications.
    Patel, S
    Shua-Haim, JR
    Patel, SR
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : S78 - S78
  • [30] Efficacy of the Combination of Tetracycline, Amoxicillin, and Lansoprazole in the Eradication of Helicobacter pylori in Treatment-Naive Patients and in Patients Who Are Not Responsive to Clarithromycin-Based Regimens: A Pilot Study
    Sezikli, Mesut
    Cetinkaya, Zuleyha Akkan
    Guzelbulut, Fatih
    Yesil, Atakan
    Altinoz, Mustafa Erhan
    Ulu, Nuriye
    Kurdas, Ayse Oya Ovunc
    GUT AND LIVER, 2012, 6 (01) : 41 - 44